Talking Strategic Development with Simtra at DCAT

Simtra BioPharma Solutions is a premier contract development and manufacturing organization (CDMO) with more than 65 years of sterile injectable (SI) experience and a dedicated focus on providing a range of services from clinical development to commercial fill/finish. Learn more about:

• Simtra’s new building in Halle that features a high-speed syringe line and vial line equipped with four lyophilizers and is expected to be GMP ready in 2024.
• The new clinical line in Bloomington that will be ready to take on projects in the summer of 2025.
• Construction of the new state-of-the-art building in Bloomington that will begin in the summer of 2024.